- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 2.80 Å
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 9 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.2: 6 residues within 4Å:- Chain C: V.139, T.140, N.153, H.170, L.172, D.318
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.4: 4 residues within 4Å:- Chain C: E.92, N.93
- Chain D: G.16, S.17
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.9: 6 residues within 4Å:- Chain C: N.293, T.295, H.327, N.329, R.440
- Ligands: NAG-NAG.3
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.12: 6 residues within 4Å:- Chain I: V.139, T.140, N.153, H.170, L.172, D.318
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.14: 4 residues within 4Å:- Chain I: E.92, N.93
- Chain J: G.16, S.17
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.19: 6 residues within 4Å:- Chain I: N.293, T.295, H.327, N.329, R.440
- Ligands: NAG-NAG.13
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.22: 6 residues within 4Å:- Chain O: V.139, T.140, N.153, H.170, L.172, D.318
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.24: 4 residues within 4Å:- Chain O: E.92, N.93
- Chain P: G.16, S.17
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.29: 6 residues within 4Å:- Chain O: N.293, T.295, H.327, N.329, R.440
- Ligands: NAG-NAG.23
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.7: 12 residues within 4Å:- Chain C: S.207, E.209, P.210, L.259, N.260, N.374, C.375, G.376, C.441, V.442, S.443
- Ligands: NAG-NAG.6
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:G.376
NAG-NAG-BMA-MAN-MAN-MAN.17: 12 residues within 4Å:- Chain I: S.207, E.209, P.210, L.259, N.260, N.374, C.375, G.376, C.441, V.442, S.443
- Ligands: NAG-NAG.16
1 PLIP interactions:1 interactions with chain I- Hydrogen bonds: I:G.376
NAG-NAG-BMA-MAN-MAN-MAN.27: 12 residues within 4Å:- Chain O: S.207, E.209, P.210, L.259, N.260, N.374, C.375, G.376, C.441, V.442, S.443
- Ligands: NAG-NAG.26
1 PLIP interactions:1 interactions with chain O- Hydrogen bonds: O:G.376
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.31: 1 residues within 4Å:- Chain C: N.138
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain C: N.232, T.234, S.272, H.349
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain C: N.336, W.392
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain D: K.122, N.126
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain D: N.100, S.102
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain I: N.138
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain I: N.232, T.234, S.272, H.349
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain I: N.336, W.392
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain J: K.122, N.126
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain J: N.100, S.102
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain O: N.138
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain O: N.232, T.234, S.272, H.349
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain O: N.336, W.392
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain P: K.122, N.126
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain P: N.100, S.102
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Caniels, T.G. et al., Precise targeting of HIV broadly neutralizing antibody precursors in humans. Science (2025)
- Release Date
- 2025-05-21
- Peptides
- RM20A3 heavy chain Fv: AGM
RM20A3 light chain Fv: BHN
GT1.1 v4.1 SOSIP gp120: CIO
Envelope glycoprotein gp160: DJP
206-9C09 heavy chain Fv: EKQ
206-9C09 kappa chain Fv: FLR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
GG
JM
OB
IH
MN
QC
AI
CO
ED
BJ
DP
FE
HK
KQ
PF
LL
NR
R
SMTL ID : 9mib.1
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
RM20A3 heavy chain Fv
Toggle Identical (AGM)RM20A3 light chain Fv
Toggle Identical (BHN)GT1.1 v4.1 SOSIP gp120
Toggle Identical (CIO)Envelope glycoprotein gp160
Toggle Identical (DJP)206-9C09 heavy chain Fv
Toggle Identical (EKQ)206-9C09 kappa chain Fv
Toggle Identical (FLR)Related Entries With Identical Sequence
4tvp.1 | 4zmj.1 | 5aco.1 | 5c7k.1 | 5cez.2 | 5cjx.1 | 5fyl.1 | 5t3x.1 | 5t3z.1 | 5thr.1 | 5u7m.1 | 5u7o.1 | 5utf.1 | 5uty.1 | 5v7j.1 | 5v8l.1 | 5v8m.1 | 5viy.1 | 5vj6.1 | 5w6d.1 | 6cm3.1 | 6crq.1 | 6de7.1 | 6did.1 | 6mn7.1 | 6mtj.1 | 6mtn.1 | 6mu6.1 | 6mu7.1 | 6mu8.1 more...less...6nf2.1 | 6nf5.1 | 6nfc.1 | 6nm6.1 | 6nnf.1 | 6nnj.1 | 6opa.1 | 6osy.1 | 6ot1.1 | 6oz4.1 | 6ozc.1 | 6pw6.1 | 6u0l.1 | 6u0n.1 | 6udj.1 | 6vi0.1 | 6vn0.1 | 6w03.1 | 6x96.1 | 6x97.1 | 6x98.1 | 6x9r.1 | 6x9r.2 | 6x9r.3 | 6x9s.1 | 6x9s.2 | 6x9s.3 | 6x9t.1 | 6x9t.2 | 6x9t.3 | 6x9u.1 | 6x9u.2 | 6x9u.3 | 6x9v.1 | 6x9v.2 | 6x9v.3 | 6xrt.1 | 7kde.1 | 7lo6.1 | 7lok.1 | 7lpn.1 | 7mdu.1 | 7mxe.1 | 7pc2.1 | 7rai.1 | 7t74.1 | 7t75.1 | 7t75.2 | 7t75.3 | 7t9a.1 | 7t9b.1 | 7tfn.1 | 7tfo.1 | 7txd.1 | 7ucf.1 | 7uoj.1 | 8dp1.1 | 8dto.1 | 8e1p.1 | 8euu.1 | 8euv.1 | 8euw.1 | 8f92.1 | 8f9m.1 | 8fis.1 | 8fk5.1 | 8fl1.1 | 8flw.1 | 8fyj.1 | 8g85.1 | 8g9w.1 | 8g9x.1 | 8g9y.1 | 8gas.1 | 8jtd.1 | 8jtm.1 | 8sal.1 | 8san.1 | 8saq.1 | 8sat.1 | 8sav.1 | 8sw3.1 | 8sw4.1 | 8t49.1 | 8t4a.1 | 8t4b.1 | 8t4d.1 | 8t4l.1 | 8tjr.1 | 8tjs.1 | 8tkc.1 | 8tl2.1 | 8tl3.1 | 8tl4.1 | 8tl5.1 | 8tng.1 | 8tnh.1 | 8tni.1 | 8tnu.1 | 8to7.1 | 8top.1 | 8tq1.1 | 8ttw.1 | 8ulr.1 | 8uls.1 | 8ult.1 | 8ulu.1 | 8vfv.1 | 9aug.1 | 9auh.1 | 9aui.1 | 9d1w.1 | 9d3d.1 | 9d8y.1 | 9d98.1 | 9ehl.1 | 9ehm.1 | 9mi0.1 | 9mia.1 | 9mih.1 | 9mii.1